1985
DOI: 10.1016/0278-6915(85)90284-4
|View full text |Cite
|
Sign up to set email alerts
|

Toxicity and neuropharmacology of cyclopiazonic acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
21
0

Year Published

1986
1986
2015
2015

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 58 publications
(21 citation statements)
references
References 30 publications
0
21
0
Order By: Relevance
“…Inhibition of these ATPases by CPA results in cell death as a result of stress response and activation of apoptotic pathways (Venkatesh andVairamuthu 2005, Vinokurova et al 2007). In mice, CPA has an LD 50 of approximately 13 mg/kg (Nishie et al 1985) making consumption of a lethal dose unlikely, especially as there is no evidence that CPA accumulates in animal tissue. However, side effects of low doses have not been ruled out as its pharmacological properties are similar to classical antipsychotic drugs like reserpine and chlorpromazine (Nishie et al 1985).…”
Section: Cyclopiazonic Acidmentioning
confidence: 98%
See 1 more Smart Citation
“…Inhibition of these ATPases by CPA results in cell death as a result of stress response and activation of apoptotic pathways (Venkatesh andVairamuthu 2005, Vinokurova et al 2007). In mice, CPA has an LD 50 of approximately 13 mg/kg (Nishie et al 1985) making consumption of a lethal dose unlikely, especially as there is no evidence that CPA accumulates in animal tissue. However, side effects of low doses have not been ruled out as its pharmacological properties are similar to classical antipsychotic drugs like reserpine and chlorpromazine (Nishie et al 1985).…”
Section: Cyclopiazonic Acidmentioning
confidence: 98%
“…In mice, CPA has an LD 50 of approximately 13 mg/kg (Nishie et al 1985) making consumption of a lethal dose unlikely, especially as there is no evidence that CPA accumulates in animal tissue. However, side effects of low doses have not been ruled out as its pharmacological properties are similar to classical antipsychotic drugs like reserpine and chlorpromazine (Nishie et al 1985). These side effects include hyperkinesias, hypothermia, Parkinson-like tremors, catalepsy, and convulsions.…”
Section: Cyclopiazonic Acidmentioning
confidence: 98%
“…Tissue samples were obtained from a CL1-0 xenograft model, which was used to confirm the inhibitory effect of citreoviridin on tumor growth in vivo (20). Immunodeficient mice carrying subcutaneous CL1-0 tumors were abdominally injected with citreoviridin or DMSO and then sacrificed when control tumors reached a size of 1000 mm 3 . Proteins from the dissected tissues were digested and processed for phosphopeptide enrichment.…”
Section: Quantitative Analysis Of Dynamic Phosphorylation Profiles Ofmentioning
confidence: 99%
“…Citreoviridin is the pathogenic factor for several diseases, including acute cardiac beriberi (3) and Keshan disease (4). Many studies have elucidated the underlying mechanism of citreoviridin cytotoxicity in different cell types.…”
mentioning
confidence: 99%
“…TG, a naturally occurring sequiterpene lactone, is a nonphorbol ester type tum or promotor [8], It induces a rapid elevation of [Ca2+]j without generation of inositol phosphates in certain cell types. It has been shown that TG is a very potent inhibitor of ER Ca2+-ATPases, less effective on cardiac sarcoplasmic reticulum (SR) Ca2+-ATPase, and apparently ineffective against the enzyme from skeletal SR and plasma membrane [9], CPA is an indole tetramic acid metabolite of Aspergillus and Pénicillium [10]. It specifically inhibits ER/SR-Ca2+-ATPase and has no effects on N a+,K+-ATPase, H +,K+-ATPase, mitochondrial Fo/ Fi-ATPase, and plasma membrane (PM) Ca2+-ATPase [11].…”
Section: Introductionmentioning
confidence: 99%